dc.contributor.author | Alizadeh, E | |
dc.contributor.author | Akbarzadeh, A | |
dc.contributor.author | Eslaminejad, MB | |
dc.contributor.author | Barzegar, A | |
dc.contributor.author | Hashemzadeh, S | |
dc.contributor.author | Nejati-Koshki, K | |
dc.contributor.author | Zarghami, N | |
dc.date.accessioned | 2018-08-26T06:04:40Z | |
dc.date.available | 2018-08-26T06:04:40Z | |
dc.date.issued | 2015 | |
dc.identifier | 10.1111/cbdd.12398 | |
dc.identifier.uri | http://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/41539 | |
dc.description.abstract | MicroRNAs are small non-coding RNAs that regulate key processes of the stem cells. Although, microRNAs have emerged as powerful regulators of differentiation, few studies have been focused on the post-transcriptional regulation of hepatic differentiation in mesenchymal stem cells (MSCs) by microRNAs. The aim of this study was to evaluate the specific effect of let-7 microRNAs in particular let-7b in hepatic commitment of human adipose tissue-derived mesenchymal stem cells (hAT-MSCs). The dynamic expression profile of let-7a, b, c microRNAs and two liver-enriched transcription factors (LETFs) HNF4a and HNF6 was studied during in vitro hepatic differentiation of hAT-MSCs. Let-7b was used for transient overexpression and knockdown investigations. It was shown that the expression of LETFs is inversely correlated with those of let-7 miRNAs during differentiation progress (p < 0.05). Inhibition of let-7b caused upregulation of LETFs, an increase in the expression of miR-122 (p < 0.01) emulating the features of functional hepatocytes, and accumulation of hAT-MSCs in the G0 /G1 phase of cell cycle, triggering initiation of hepatic commitment. In conclusion, transient inhibition of let-7b activates hepatic differentiation of hAT-MSCs. The findings of this work might help optimization of in vitro hepatogenic differentiation utilizing microRNAs and hAT-MSCs that could be used for therapeutic purposes. | |
dc.language.iso | English | |
dc.relation.ispartof | Chemical biology & drug design | |
dc.subject | Adipose Tissue | |
dc.subject | Adult | |
dc.subject | Cell Differentiation | |
dc.subject | Cell Survival | |
dc.subject | Cells, Cultured | |
dc.subject | Female | |
dc.subject | G1 Phase Cell Cycle Checkpoints | |
dc.subject | Hep G2 Cells | |
dc.subject | Hepatocyte Nuclear Factor 4 | |
dc.subject | Hepatocyte Nuclear Factor 6 | |
dc.subject | Hepatocytes | |
dc.subject | Humans | |
dc.subject | Liver | |
dc.subject | Male | |
dc.subject | Mesenchymal Stromal Cells | |
dc.subject | MicroRNAs | |
dc.subject | Middle Aged | |
dc.subject | Oligonucleotides, Antisense | |
dc.subject | Up-Regulation | |
dc.title | Up regulation of liver-enriched transcription factors HNF4a and HNF6 and liver-specific microRNA (miR-122) by inhibition of let-7b in mesenchymal stem cells. | |
dc.type | article | |
dc.citation.volume | 85 | |
dc.citation.issue | 3 | |
dc.citation.spage | 268 | |
dc.citation.epage | 79 | |
dc.citation.index | Pubmed | |
dc.identifier.DOI | https://doi.org/10.1111/cbdd.12398 | |